Besides following our news, follow us on socials networks :
What services TransCure bioServices is offering? Who are its clients? What are its achievements? What are its news goals and new challenges with its recent funding of 2.5 million euros? Get the answers in the ECO article. (article n french).
New financing round will enable the company to accelerate its growth and expand its international services offers.
Strategic partnership with Champions Oncology, Inc
TransCure bioServices SAS was selected for the SME instruments call-to-offer Phase 1 with 273 companies out of 2’822 applicants.
TransCure bioServices hires Adrien MOSSU – New Deputy Project Officer
INSERM publishes first in vivo proof of concept of an engineered Chimeric Antigen Receptor T cell directed against IL-1RAP expressed by leukemia stem cells using TransCure’s full human immune system hu-mouse models.